EU Commission is negotiating with the Mainz-based manufacturer BioNTech and its US partner Pfizer about the possibility of buying more coronavirus vaccines, APA reports citing Sputnik.
The commission is examining whether they can get more doses beyond the contractually agreed 300 million vaccine doses, says a spokesman for the Brussels authority, with rumours of the commission seeking an extra 100 million doses.
“The Commission is checking whether there is a way to add additional doses to those for which we already have a deal,” the spokesman said.
Follow us on Telegram
t.me/apanewsaz
Follow us on Instagram
Follow us on Facebook
Follow us on Twitter
